ATM John Berry. What is ATM? Named “ATM” for “Ataxia-telangiectasia Mutated” gene. The mutation is recessive. Named “ATM” for “Ataxia-telangiectasia Mutated”

Slides:



Advertisements
Similar presentations
Telomeres and epigenetics
Advertisements

P53 The Master Guardian of the Genome. p53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
Cancer: a genetic disease of inherited and somatic mutations n Gene mutations and/or genetic instability are involved in many cancers. n Viruses and environmental.
A signal transducer and cancer Neurofibromin, ras, and cancer - utah.
P53 The Master Guardian. R point Cell cycle control involves several checkpoints and checkpoint (molecular breaking) mechanisms.
FANCD2 FANCONI ANEMIA PROTEIN COMPLEMENTATION GROUP D2 by Meredith Binkley.
ATM, Ataxia Telangiectasia, & Cancer
P53 gene mutations in human tumors Greenblatt et al. (1995) Cancer Res. 54: %
Ataxia Telangiectasia (AT) By Brandy Chapman. Characteristics of Ataxia- telangiectasia: Progressive neuronal degeneration Loss of cerebellar function.
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
Cellular Responses to DNA Damage Kate Dixon Department of Molecular and Cellular Biology
BRCA Genes Dallas Henson.
Ataxia- telangiectasia Mutated (ATM) Brooke Register.
Cancer Cell cycle, oncogenes and tumour suppressors Jake Turner.
And Its Role in Ataxia Telangiectasia
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
Malignant Melanoma and CDKN2A
Cyclins G1 cyclin (cyclin D) S-phase cyclins (cyclins E and A) mitotic cyclins (cyclins B and A) Cyclin-dependent kinases (Cdks)kinases G1 Cdk (Cdk4) S-phase.
SC430 Molecular Cell Biology
1 H2AX: functional roles and potential applications.
Bloom’s Syndrome and Bloom helicase Alexandra Otto March 16, 2004.
Outline Introduction Pathophysiology Signs & Symptoms Complications Diagnosis Treatment Prevention Ataxia Telangiectasia like Disorder.
ATAXIA TALANGIECTASIA
Group Number: 2 Britney Porter, Sandra Nguyen, Eduardo Vargas and Samender Singh Randhawa.
Definition of Xeroderma Pigmentosum: XP XP, first described in 1874, is a rare genetic defect in the nucleotide excision repair mechanism. It is characterized.
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
Smad4 in Colon & Pancreatic Cancers
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Growths in Your Colon Aren’t Fun, Get Yourself Some LKB1! Abstract Billions of dollars are being poured into the research of cancer, the National Cancer.
Bonny Blackard Biology 169 April 4, 2006
Cancer Basics EQ: What does cancer have to do with the cell cycle?
CHAPTER 19 THE ORGANIZATION AND CONTROL OF EUKARYOTIC GENOMES Copyright © 2002 Pearson Education, Inc., publishing as Benjamin Cummings Section D: The.
Lisa Harrison.  A deviation from the individual’s normal state of physical, mental, and social well being, leading to a loss of homeostasis in the body.
Genetics of Cancer Genetic Mutations that Lead to Uncontrolled Cell Growth.
Natasha Adlakha Bio445. Discovery in Breast Cancer Reverse Genetics BReast CAncer Gene Chromosome 13 Tumor suppressor gene Penetrance Familial,
Tumor Suppressor Gene Involved in Breast and Ovarian Cancers SCIENCE96/gene.cgi?BRCA1.
PTEN (Cowden Syndrome) /.../ sld083.htm.
BLOOM HELICASE (and BLOOM SYNDROME)
Cowden’s Disease and PTEN. Cowden’s Disease (CD)  A rare autosomal dominant disease similar to Lehrmitte-Duclos Disease (LDD) and Bannayan-Zonana Syndrome.
Spider nevus It is also called a spider angioma or a Nevus areneus. These are common acquired vascular lesions present in over 1O% of healthy adults. They.
 Complete the bellwork and glue on page 26 of INB Do Now 1/28.
Catchy LKB1 Title Abstract Billions of dollars are being poured into the research of cancer, the National Cancer Institute alone spends $4.9 Billion every.
Gene Expression and Retinoblastoma “Cancer of the Eye”
Kate Bradford BIOL 445 March 5, 2009
Targeting the DNA Damage Response in Cancer
Figure: Caption: The cell cycle is controlled at several checkpoints, including one at the G2/M transition, and another in late G1 phase before.
Xeroderma Pigmentosum, XPF
Chapter 5.2: Cancer.
Ataxia- Telangiectasia and ATM
PTEN (a.k.a. MMAC1 and TEP1) and Cowden’s Disease
Discovery of Tumor Suppressor Genes
The Role of MSH2 in Hereditary Non-Polyposis Colon Cancer
Figure 1 Putative anticancer mechanisms of action of PARP inhibitors
Bloom Helicase & Bloom Syndrome
Identification and characterization of polymorphic variations of the ataxia telangiectasia mutated (ATM) gene in childhood Hodgkin disease by Masatoshi.
ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and missense mutations involving the phosphatidylinositol-3 kinase.
PTEN Tumor Suppressor and Cancer
FANCF methylation contributes to chemoselectivity in ovarian cancer
Ataxia telangiectasia and the Role of ATM
A Knockout for Lynch Syndrome
Volume 3, Issue 4, Pages (April 2003)
ATM Creates a Veil of Transcriptional Silence
Do Now 1/28 Complete the bellwork and glue on page 26 of INB.
Figure 1 Chronic inflammation and DNA damage in people with SLE
Genetic ablation of genes encoding PI3K components blocked the prostate tumorigenesis caused by PTEN loss. Genetic ablation of genes encoding PI3K components.
Maintenance of telomere length in AML
ATM function in repair of double-stranded DNA breaks.
Model for the regulation of HIPK2 activity and p53 phosphorylations by the ATM pathway. Model for the regulation of HIPK2 activity and p53 phosphorylations.
Volume 3, Issue 4, Pages (April 2003)
Presentation transcript:

ATM John Berry

What is ATM? Named “ATM” for “Ataxia-telangiectasia Mutated” gene. The mutation is recessive. Named “ATM” for “Ataxia-telangiectasia Mutated” gene. The mutation is recessive. Ataxia-telangiectasia (or AT) is a neurodegenerative disease that is normally detected in infancy to early childhood. Ataxia-telangiectasia (or AT) is a neurodegenerative disease that is normally detected in infancy to early childhood. AT patients have shown a predisposition to Lymphoma, so ATM was suspected as a tumor suppressing gene. AT patients have shown a predisposition to Lymphoma, so ATM was suspected as a tumor suppressing gene.

AT Symptoms Symptoms: ataxia, telangiectasia, and impairing of the immune system Symptoms: ataxia, telangiectasia, and impairing of the immune systemhttp://my.webmd.com/hw/health_guide_atoz/nord406.asp

AT Symptoms Symptoms: ataxia, telangiectasia, and impairing of the immune system Symptoms: ataxia, telangiectasia, and impairing of the immune systemhttp://

AT Effects Patients are subject to sinopulmonary infections Patients are subject to sinopulmonary infections Increased occurrence of malignant tumors. Increased occurrence of malignant tumors. Patients have a short life-expectancy. Patients have a short life-expectancy.

ATM P(3)IK Serine-Threonine Kinase P(3)IK Serine-Threonine Kinase Located in the Nucleus Located in the Nucleus Normally inactivated Normally inactivated Rapid activation in response to Double Strand Break (DSB) Rapid activation in response to Double Strand Break (DSB) Substrate list is not presently complete. Substrate list is not presently complete.

ATM Function

ATM Substrates

ATM Checkpoint Functions ATM Checkpoint Functions Shiloh, Yosef. “ATM AND RELATED PROTEIN KINASES: SAFEGUARDING GENOMEINTEGRITY.” Nature Reviews Cancer. Volume 3 March 2003 pg

Repair McKinnon, Peter J. “ATM and Ataxia telangiectasia.”Embo Reports. Vol 3 (8) pg

ATM knockout in Mice ATM -/-: Lymphoma in 2-4 months ATM -/-: Lymphoma in 2-4 months Heterozygous mice are predisposed. Heterozygous mice are predisposed. Loss of Heterozygosity is required in most cases Loss of Heterozygosity is required in most cases Barlow, C, et al. “Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell Jul 12;86(1):

Evidence for the Pathway

ATM +/-, p53 +/- Mice Irradiated double heterozygous mice show the highest incidence of carcinogenesis research.com/content/pdf/bcr9 68.pdf

ATM mutations in Human Cancer A-T Patients are not the main health concern, but rather carriers of A-T. A-T Patients are not the main health concern, but rather carriers of A-T. Most heterozygous individuals do not show a pre-disposition to cancer Most heterozygous individuals do not show a pre-disposition to cancer Discovery of the dominant negative Discovery of the dominant negative Shiloh, Yosef. “ATM AND RELATED PROTEIN KINASES: SAFEGUARDING GENOMEINTEGRITY.” Nature Reviews Cancer. Volume 3 March 2003 pg

ATM Function

Future Directions Despite a limited risk group, ATM is still important for research. Despite a limited risk group, ATM is still important for research. Damage repair is a key component of homeostasis. Damage repair is a key component of homeostasis.

Any Questions?